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Abstract 34 
 35 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is considered a 36 
multifunctional protein with defined functions in numerous mammalian cellular processes. 37 
GAPDH functional diversity depends on various factors such as covalent modifications, 38 
subcellular localization, oligomeric state and intracellular concentration of substrates or 39 
ligands, as well as protein-protein interactions. In bacteria, alternative GAPDH functions 40 
have been associated with its extracellular location in pathogens or probiotics. In this study, 41 
new intracellular functions of E. coli GAPDH were investigated following a proteomic 42 
approach aimed at identifying interacting partners using in vivo formaldehyde cross-linking 43 
followed by mass spectrometry. The identified proteins were involved in metabolic 44 
processes, protein synthesis and folding or DNA repair. Some interacting proteins were also 45 
identified in immunopurification experiments in the absence of cross-linking. Pull-down 46 
experiments and overlay immunoblotting were performed to further characterize the 47 
interaction with phosphoglycolate phosphatase (Gph). This enzyme is involved in the 48 
metabolism of 2-phosphoglycolate formed in the DNA repair of 3’-phosphoglycolate ends 49 
generated by bleomycin damage. We show that interaction between Gph and GAPDH 50 
increases in cells challenged with bleomycin, suggesting involvement of GAPDH in 51 
cellular processes linked to DNA repair mechanisms. 52 
 53 
Keywords: moonlighting proteins; glyceraldehyde-3-phosphate dehydrogenase; protein-54 
protein interactions; phosphoglycolate phosphatase; DNA repair; Escherichia coli 55 
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Abbreviations: CAA, casein acid hydrolysate CAA; CFUs, colony forming units; FA, 58 
formaldehyde; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Gph, 59 
phosphoglycolate phosphatase; GST, glutathione-S-transferase; MS, mass spectrometry; 60 
NBRP, National BioResource Project; PVDF, polyvinylidene difluoride.61 
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1. Introduction 62 
 63 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12), a key enzyme 64 
in the glycolytic pathway, is not merely a classical metabolic protein, but is also considered 65 
a multifunctional protein with defined functions in numerous mammalian cellular processes 66 
(reviewed in Sirover, 1999, 2005, 2011). This protein is involved in transcriptional and 67 
post-transcriptional gene regulation, chromatin structure, intracellular membrane 68 
trafficking, DNA replication and DNA repair processes (Sirover, 2011). Each new function 69 
requires GAPDH association into specific protein complexes. The functional diversity of 70 
GAPDH depends on various factors, such as covalent modifications, subcellular 71 
localization, oligomeric state, or intracellular concentration of substrates (Jeffery, 2004; 72 
Sirover, 2005, 2011). In this context, it is important to consider the great diversity of post-73 
translational modifications described for GAPDH, which may underpin its multifunctional 74 
activity (Sirover, 2011). Many of these modifications are associated with various types of 75 
stress (Cabiscol and Ros, 2006; Colussi et al., 2000; Eaton et al., 2002). 76 
In bacteria, alternative GAPDH functions have been associated with its extracellular 77 
location in pathogens. GAPDH is one of the housekeeping proteins that are secreted and 78 
exposed on the bacterial surface, enabling the pathogens to colonize and persist in the host 79 
(Pancholi and Chhatwal, 2003). Several reports on different gram-positive pathogens have 80 
demonstrated the ability of extracellular GAPDH to interact with various host components 81 
such as transferrin, plasminogen, extracellular matrix components or the urokinase 82 
plasminogen activator receptor (Jin et al., 2005; Schaumburg et al., 2004; Seifert et al., 83 
2003). In the case of the gram-negative pathogens enteropathogenic E. coli (EPEC) and 84 
enterohaemorrhagic E. coli (EHEC), our group showed that secreted GAPDH is able to 85 
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interact with human plasminogen and fibrinogen, and remains associated with Caco-2 cells 86 
upon infection (Egea et al., 2007). Extracellular GAPDH can also act as a target for 87 
oxidation and therefore may protect bacteria against host oxidative response (Aguilera et 88 
al., 2009). In recent years, GAPDH has been identified in the secretome of probiotic strains 89 
(Aguilera et al., 2012; Sanchez et al., 2009a, 2009b). Extracellular GAPDH may confer 90 
these strains an advantage in gut colonization with respect to other components of the 91 
intestinal microbiota. Besides the role of secreted GAPDH in host colonization processes, 92 
no studies of new GAPDH intracellular functions have been described so far in bacteria. 93 
In the area of systems biology, the identification of protein-protein interactions 94 
within cells is of prime importance to understand biological processes at the molecular 95 
level. Several groups have performed large-scale analyses using E. coli to identify 96 
interactions between proteins (Arifuzzaman et al., 2006; Butland et al., 2005). These 97 
studies, based on tagged protein baits that allow affinity purification of the interacting 98 
proteins, have shown that GAPDH interacts with a range of proteins, including metabolic 99 
enzymes and proteins involved in transcription or protein synthesis, suggesting the 100 
potential role of E. coli GAPDH in some cellular processes similar to those described in 101 
humans.  102 
When using these affinity-based methods, transient interactions or weakly binding 103 
proteins can be lost during washing procedures. As an alternative, in vivo chemical cross-104 
linking experiments can be performed to covalently fix interaction partners in living cells, 105 
thus preventing the loss of specific components of a protein complex prior to purification 106 
(Sinz, 2010). Although formaldehyde is widely used as a cross-linker in chromatin 107 
immunoprecipitation experiments, the number of studies which have used this reagent in 108 
combination with mass spectrometry (MS) to investigate protein-protein interaction is 109 
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limited (Sinz, 2010). Examples of this approach are the identification of new proteins 110 
interacting with a constitutive active form of M-Ras (Vasilescu et al., 2004) or the 111 
identification of glutamate dehydrogenase as a protein that interacts with the regulator GltC 112 
in Bacillus subtilis (Herberg et al., 2007). 113 
To explore new GAPDH functions in E. coli, in this study we conducted in vivo 114 
formaldehyde cross-linking experiments followed by MS to identify proteins interacting 115 
with V5-tagged GAPDH in E. coli. We also characterized interaction with 116 
phosphoglycolate phosphatase (Gph), an enzyme involved in the metabolism of 2-117 
phosphoglycolate, a compound formed in the DNA repair of 3’-phosphoglycolate ends 118 
generated by bleomycin damage (Pellicer et al., 2003). 119 
 120 
 121 
2. Materials and methods 122 
 123 
2.1. Bacterial strains and growth conditions 124 
The genotypes and sources of the E. coli strains used in this study are as follows. Strain 125 
MC4100 (F- araD ∆(argF-lac) rpsL(Strr) relA fihD deoC ptsF rbs) (Casadaban, 1976) was 126 
the source of chromosomal DNA used as a template for PCR amplification of gene gapA. 127 
The mutant strain JA210 (gph::Kan) was derived from MC4100 (Pellicer et al., 2003). 128 
Strain TOP10 (F- ∆mrcA (mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 129 
∆(ara-leu)7697 galU galK rpsL(Strr) endA1 nupG) was used to express recombinant 130 
GAPDH-V5 (Invitrogen). Strain BL21(DE3) (F- ompT hsd(rB- mB-) gal) was used as a host 131 
to express GST-tagged proteins (Amershan Pharmacia). Strain AG1 (ME5053) (recA1 132 
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endA1 gyrA96 thi-1 hsdR17(rK- mK-) supE44 realA1) was the host for recombinant 133 
pCA24N plasmids expressing His-tagged proteins (NBRP, National BioResource Project). 134 
Bacterial cells were routinely grown at 37ºC in Luria-Bertani broth (LB). In bleomycin 135 
challenge experiments, cells were grown in minimal medium with 0.5% casein acid 136 
hydrolysate (CAA) as carbon source (Pellicer et al., 2003). Growth was monitored by 137 
measuring the optical density at 600 nm (OD600). When required, tetracycline (12.5 µg/ml), 138 
chloramphenicol (30 µg/ml) or ampicillin (100 µg/ml) was added to the medium. 139 
 140 
2.2. Recombinant DNA techniques and site-directed mutagenesis 141 
Bacterial genomic DNA was obtained using the Wizard Genomic DNA purification kit 142 
(Promega), and plasmid DNA was prepared using the Wizard Plus SV Midipreps DNA 143 
purification system (Promega). DNA manipulations were performed essentially as 144 
described elsewhere (Sambrook and Rusell, 2001). DNA fragments were amplified by PCR 145 
using E. coli chromosomal DNA as a template. PCR reactions were performed with Taq 146 
DNA polymerase or pfu DNA polymerase under standard conditions. DNA sequencing was 147 
carried out with an automated ABI 377 DNA sequencer and fluorescent dye termination 148 
methods.  149 
 150 
2.3. Cloning of recombinant V5-tagged GAPDH  151 
To construct recombinant GAPDH-V5, the pBAD TOPO® TA Expression Kit 152 
(Invitrogene) was used. This system provides a highly efficient, one-step cloning strategy 153 
for the direct insertion of Taq polymerase-amplified PCR products into a plasmid vector for 154 
regulated expression in E. coli. Expression is driven by the araBAD promoter, thus 155 
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induction of the cloned gene is achieved by the addition of L-arabinose to the culture 156 
medium. The gapA gene from strain MC4100 was amplified by PCR with primers gapA-157 
pBAD-fw (TAGGGTGGAATATATGACTATCAAAGTAGG) and gapA-pBAD-rv 158 
(TTTGGA GATGTGAGCGATCAGG). To express GAPDH with its native N-terminal 159 
end (without the N-terminal leader), the forward primer was designed with an in-frame stop 160 
codon (TAG, underlined) at the 5’-end followed by the native gapA sequence including the 161 
ribosome binding site and the start codon (in bold). The gapA stop codon was removed 162 
from the reverse primer to allow expression of GAPDH fused at its C-terminal end to the 163 
V5 epitope. The PCR fragment was cloned into plasmid pBAD-TOPO (Invitrogen) and 164 
after transformation of strain TOP10, recombinant colonies were selected on LB- ampicillin 165 
plates. Plasmid DNA was sequenced to ensure that the fragment was inserted in the correct 166 
orientation and that no mutations were introduced. The recombinant plasmid was named 167 
pBAD-GapA. 168 
 169 
2.4. In vivo cross-linking with formaldehyde 170 
Cells of strain TOP10 bearing the recombinant plasmid pBAD-GapA were grown at 171 
37ºC in 10 ml of LB-ampicillin until the culture reached an OD600 of 0.5. At this point L-172 
arabinose was added at a final concentration of 0.02% to induce the expression of GAPDH-173 
V5. After a 3 h induction, formaldehyde was added at a final concentration of 1%. 174 
Formaldehyde cross-linking was allowed to proceed for 20 min at 37ºC. To stop the cross-175 
linking reaction, glycine was added at a final concentration of 0.5 M and after 5 min at 176 
room temperature, bacterial cells were harvested by centrifugation, washed twice with PBS 177 
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3), and 178 
resuspended in 0.4 ml of PBS containing a cocktail of protease inhibitors (Roche 179 
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Diagnostic). Cell extracts were obtained by sonic disruption of bacterial cells followed by 180 
centrifugation to remove cell debris. Protein concentration was determined using the 181 
method described by Lowry et al. (1951) with bovine serum as a standard. 182 
 183 
2.5. Immunoprecipitation of recombinant GAPDH-V5  184 
Purification of GAPDH-V5 cross-linked complexes was performed by 185 
immunoprecipitation using anti-V5 agarose beads (Sigma-Aldrich, Germany). To reduce 186 
unspecific interactions, the binding and washing steps were carried out under astringent 187 
conditions with RIPA buffer (1% sodium deoxycholate, 0.1% SDS, 1% Triton X-100, 0.14 188 
M NaCl, 0.01 M Tris-HCl, pH 8.0). Cell extracts were precleared with protein G-agarose 189 
beads for 10 min at 4ºC. Precleared cell extracts containing 1.4 mg of protein were adjusted 190 
to a final volume of 0.8 ml with RIPA buffer and incubated with 250 µl of anti-V5 beads 191 
for 90 min at 4ºC in an orbital shaker. After five washes with RIPA buffer and two 192 
additional washes with TBS buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.6), the bound 193 
complexes were eluted with 0.1 M glycine (pH 2.5) for 15 min at 37ºC and neutralized with 194 
a saturated Tris base solution. Protein from the eluted fractions was precipitated with 195 
acetone (at room temperature to minimize SDS precipitation), rinsed three times in acetone, 196 
and resuspended in loading buffer. Samples were then heated for 30 min at 95ºC to reverse 197 
the formaldehyde cross-links. Proteins were separated on a 10% SDS–polyacrylamide gel 198 
electrophoresis (SDS-PAGE) (Laemmli, 1970) and visualized by Sypro® Ruby staining. 199 
Immunoprecipitation experiments with anti-V5 agarose beads were also carried out 200 
to identify proteins that interact with GAPDH without previous cross-linking. In this case, 201 
precleared cell extracts containing 1.4 mg of protein were adjusted to a final volume of 0.8 202 
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ml with PBS buffer and incubated with anti-V5 beads as described above. After five 203 
washes with PBS buffer, proteins were eluted with 0.1 M glycine (pH 2.5) for 15 min at 204 
37ºC, neutralized and precipitated by incubation on ice with 10% trichloroacetic acid 205 
(TCA). The protein pellet was washed in 90% (v/v) ice-cold acetone, air-dried and 206 
suspended in rehydration buffer (9M urea, 4% CHAPS, 50 mM dithiothreitol, 0.5% 207 
immobilized pH gradient buffer and traces of bromophenol blue) and processed for two-208 
dimensional gel electrophoresis. 209 
 210 
2.6. Two-dimensional gel electrophoresis 211 
 2D gel electrophoresis was performed using the Protean IEF-Cell (Bio-Rad). 212 
Appropriate volumes of protein samples (5 µg of purified recombinant GAPDH) were 213 
diluted in 125 µl of rehydration buffer (9 M urea, 4% CHAPS, 50 mM dithiothreitol, 0.5% 214 
immobilized pH gradient buffer and traces of bromophenol blue). Isoelectric focusing was 215 
performed in immobilized pH 3-10 or pH 5-8 gradient strips (BioRad). Second dimension 216 
SDS-PAGE was performed on 12.5% acrylamide gels that were processed for 217 
immunoblotting analysis. Parallel gels were silver-stained to visualize total protein. 218 
 219 
2.7. Mass spectrometry of proteins 220 
Following SDS-PAGE, protein bands of interest were excised from the gel and 221 
sequentially washed with 25 mM ammonium bicarbonate and acetonitrile. These samples 222 
were then reduced (10 mM DTT, 30 min at 56ºC), alkylated (55 mM iodoacetamide, 15 223 
min at 21ºC) and digested overnight with tripsin (Tripsin Gold, Promega) at 37ºC in an 224 
automatic Investigator ProGest robot (Genomic Solutions). Peptides were extracted with 225 
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10% formic acid and analysed by combined liquid chromatography / tandem mass 226 
spectrometry (Cap-LC-nano-ESI-Q-TOF) (CapLC, Micromass-Waters) at the Barcelona 227 
Science Park (PCB) Proteomics Platform. Data were generated in PKL file format and 228 
submitted to a MASCOT server for database searching.  229 
Protein spots from 2D gels were analysed using the liquid chromatograph nanoAcquity 230 
(Waters) coupled to a mass spectrometer (OrbitrapVelos, Thermo Scientific). Raw data 231 
were obtained with Thermo Xcalibur (v.2.1.0.1140) and used for database searching with 232 
the Proteome Discoverer software package (v.1.2.0.124). 233 
 234 
2.8. Expression and purification of recombinant proteins 235 
Recombinant GAPDH and Gph were expressed and purified using the Glutathione-S-236 
transferase (GST) gene fusion system with recognition sites for factor Xa cleavage as 237 
described in detail previously (Egea et al., 2007; Pellicer et al., 2003).  238 
When indicated, Gph was expressed as His6-Gph from the ASKA clone JW3348 239 
(NBRP, E. coli Strain National BioResource Project) and purified under native conditions 240 
with Ni2+-nitrilotriacetic acid (NTA) resin (Qiagen), as described elsewhere (Kitagawa et 241 
al., 2005). The same procedure was applied for expression and purification of the ATP 242 
synthase β subunit (His6-AtpD) and the ATP synthase α subunit (His6-AtpA) from the 243 
ASKA clones JW3710 and JW3712, respectively. Due to the low level expression of 244 
soluble His6-AtpD, purification of this protein was achieved from a 100 ml culture of strain 245 
AG1 after overnight induction with 0.1 mM IPTG at 20ºC. Cell pellets were suspended in 1 246 
ml of 50 mM sodium phosphate buffer (pH 8.0) containing 300 mM NaCl and 10 mM 247 
imidazole, and sonicated on ice. The cell lysate was centrifuged at 15000 g and the 248 
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supernatant incubated with 0.1 ml of Ni2+-NTA resin for 1 h at 4ºC with gentle shaking. 249 
After loading the mixture into a column, the resin was washed with the same buffer but 250 
containing 20 mM imidazole. Recombinant proteins were eluted with 0.1 ml of elution 251 
buffer containing 300 mM imidazole, followed by SDS-PAGE and immunoblotting 252 
analysis.  253 
 254 
2.9. Immunoblotting analysis  255 
 For Western blot analysis, protein samples were separated on 10% SDS-PAGE and 256 
transferred to a HyBond-P polyvinylidene difluoride (PVDF) membrane by using a Bio-257 
Rad MiniTransblot apparatus. The membrane was blocked in PBS-0.05% Tween-20 and 258 
5% skimmed milk (blocking solution) for 1 h at room temperature, incubated with primary 259 
specific antibodies against GAPDH (Egea et al., 2007) (1:5,000 dilution in blocking 260 
solution) for 16 h at 4°C, washed four times with PBS-0.05% Tween-20 and incubated with 261 
the secondary antibody (donkey anti-rabbit immunoglobulin horseradish peroxidase-linked, 262 
diluted 1:15,000 in blocking solution). Incubation with the secondary antibody was omitted 263 
when anti-V5 (Invitrogen; 1:15,000 dilution) or anti-GST (GenScript; 1:5,000 dilution) 264 
horseradish peroxidase-linked antibodies were used as primary antibody. The protein-265 
antibody complex was visualized using the ECL Plus Western blotting detection system 266 
(Amersham Pharmacia Biotech).  267 
Binding of GAPDH to Gph was analysed by Far-Western assays (overlay 268 
immunoblotting). In this case, purified GAPDH was subjected to 2D gel electrophoresis as 269 
described above. After being blocked overnight with 1% gelatin in TBS buffer, the 270 
membrane was incubated with purified Gph (5 µg/ml) diluted in the same blocking buffer 271 
13 
 
 
for 3 hours and then washed four times in TBS-0.05% Tween-20. To visualize interaction 272 
of GAPDH with Gph, the membrane was incubated with anti-Gph specific antibodies 273 
(1:5,000 dilution TBS-1% gelatin-0.05% Tween-20) for 16 h at 4ºC, and processed as 274 
described above using the ECL Western blotting kit to visualize the reactive spots. The 275 
incubation step with purified Gph was omitted as negative control.  276 
The anti-Gph antibodies used in this study were purified by affinity chromatography. 277 
For this purpose, purified Gph was covalently linked to UltralinkTM Immobilized DADPA 278 
on 3 M Emphase Biosupport medium AB1 gel (Pierce) using water-soluble 1-ethyl-3-(3-279 
dimethylamino-propyl)carbodiimide-HCl. To purify the anti-Gph immunoglobulin, 3 ml of 280 
the globulin fraction partially purified from the Gph-antisera (Pellicer et al., 2003) was 281 
applied to the DADPA-Gph affinity column and the bound antibodies were eluted with 0.1 282 
M glycine buffer (pH 2.5). Collected fractions were neutralized with Tris solution (pH 10) 283 
and dialysed overnight against PBS. 284 
 285 
2.10. Bleomycin cell treatment  286 
Cells of strain JA210 bearing plasmid pGEX-Gph (Pellicer et al., 2003) were grown 287 
aerobically in minimal medium with 0.5% CAA to mid-exponential phase (OD600 of 0.5). 288 
After a 2 hour induction of GST-Gph expression with 0.5 mM IPTG, the culture was 289 
treated with 8 µg/ml bleomycin in the presence of 50 µM FeSO4. At different times, 290 
aliquots of the culture were collected, washed twice with minimal medium and processed to 291 
obtain the cell extracts. Interaction between Gph and GAPDH was evaluated by pull-down 292 
experiments followed by Western blot analysis with antibodies against GAPDH. Survival 293 
was estimated by diluting cells in the same medium, followed by plating on LB-ampicillin 294 
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plates to determine the number of colony forming units (CFUs). Bleomycin sulphate 295 
(Almirall Prodesfarma, Barcelona, Spain) was freshly prepared with 50 mM phosphate 296 
buffer (pH 7.5). FeSO4 solutions were prepared immediately before use. 297 
 298 
 299 
3. Results and discussion 300 
 301 
3.1. Immunoaffinity purification of proteins cross-linked to GAPDH-V5 and their 302 
identification by mass spectrometry 303 
Cultures of TOP10 cells expressing V5-tagged GAPDH were treated with 304 
formaldehyde and the GAPDH-V5 containing complexes were analysed in the cell extracts 305 
by Western blotting with either anti-V5 or anti-GAPDH antibodies. As control, TOP10 306 
cells without the recombinant pBAD-GapA plasmid were processed in parallel. As shown 307 
in Fig. 1A, protein bands ranging in size from 70 kDa to 160 kDa were only detected above 308 
recombinant GAPDH-V5 (37 kDa) in cells treated with the cross-linker. The most apparent 309 
bands corresponded to high molecular protein complexes in accordance with the native 310 
GAPDH tetramer structure. The presence of protein complexes with a molecular mass 311 
lower than 160 kDa indicates that other oligomeric or monomeric GAPDH-V5 forms were 312 
being cross-linked with E. coli proteins. To set up the conditions for cross-linking reversal, 313 
cell extracts were incubated at 65ºC or 95ºC in loading buffer and at the indicated times, 314 
reversion of the cross-links was analysed by Western blotting with anti-V5 antibodies (Fig. 315 
1B). The high molecular mass complexes produced by formaldehyde treatment were no 316 
longer detected after 30 min incubation at 95ºC. These conditions were selected for further 317 
experiments. 318 
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In order to identify the proteins that were cross-linked to GAPDH-V5, precleared 319 
cell extracts obtained from TOP10 (pBAD-GapA) cells challenged with formaldehyde were 320 
incubated with anti-V5 beads. After astringent washing steps, bound material was eluted as 321 
described in section 2.5. Cell extracts obtained from non formaldehyde-treated TOP10 322 
(pBAD-GapA) cells were processed in parallel. Purified complexes were concentrated by 323 
acetone precipitation, resuspended in loading buffer and processed to reverse formaldehyde 324 
cross-links. Proteins were separated by SDS-PAGE. Staining with Sypro® Ruby revealed 325 
several proteins in the cross-linked sample that were not visible in the lane corresponding to 326 
non-treated cells (Fig. 2). These differential proteins were selected for further analysis. In 327 
the absence of formaldehyde treatment, co-purification of native GAPDH (band 2) with 328 
recombinant GAPDH-V5 (band 3) under astringent conditions (Fig. 2, - FA lane, Table 1) 329 
indicated a strong interaction of GAPDH monomers compatible with the stable tetrameric 330 
structure reported for this protein.  331 
Twelve major bands were excised from the cross-linked sample (Fig. 2, + FA lane) 332 
and digested with trypsin. Peptides were extracted and analysed by combined liquid 333 
chromatography / tandem mass spectrometry (Cap-LC-nano-ESI-Q-TOF). Database 334 
searching in MASCOT resulted in the identification of 16 proteins, each of which matched 335 
to at least 3 unique peptide sequences (Table 1). Among the identified proteins, there were 336 
several metabolic enzymes, chaperones and factors involved in protein synthesis. 337 
Four proteins (trigger factor, DnaK, Gph and aldehyde dehydrogenase (AldA)) also 338 
appeared as candidates for interaction with GAPDH in other studies of E. coli or in 339 
databases such as DIP (database of interacting proteins) or IntAct. The chaperones DnaK 340 
(P0A6Y8) and trigger factor (P0A850) were identified in large-scale analyses 341 
(Arifuzzaman et al., 2006; Butland et al., 2005). Trigger factor interacts with the large 342 
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ribosomal subunit near the peptide exit channel and binds to nascent polypeptides to assist 343 
cotranslational protein folding. Therefore, interaction of GAPDH-V5 with this chaperone is 344 
likely to occur during the synthesis of the recombinant polypeptide. In addition, trigger 345 
factor has been shown to prevent aggregation and promote refolding of denatured GAPDH 346 
in vitro (Huang et al., 2000). GAPDH has also been identified as a substrate of DnaK 347 
(Deuerling et al., 2003). Both trigger factor and DnaK share a common substrate pool in 348 
vivo and cooperate to ensure proper folding of the cytosolic proteins (Deuerling et al., 1999, 349 
2003). Thus, interaction between the synthesized recombinant protein and these chaperones 350 
is expected to occur in cells grown at 37ºC.  351 
GAPDH was identified as a putative interacting partner of Gph (P32662) in the 352 
large-scale study performed by Arifuzzaman et al. (2006). In this case, the interaction was 353 
observed with His6-Gph used as the bait in pull-down experiments. Regarding the 354 
interaction with AldA (P25553), information available on the IntAct database 355 
http://www.ebi.ac.uk/ intact/pages/interactions/ interactions) corroborates our results. Both 356 
GAPDH and AldA were identified together with L-asparaginase-2 (P00805) as partners of 357 
a protein complex resolved by native-PAGE.  358 
The other proteins identified in this study as putative partners of GAPDH 359 
interactions (Table 1) have not been experimentally isolated in previous studies. However, 360 
some of them are predicted to be functional partners of GAPDH in the STRING interaction 361 
network (http://string-db.org/newstring_cgi/ show_network_ section.pl). Enolase and 362 
transketolase belong to this group. Other proteins may establish weak or transient 363 
interactions with GAPDH, being captured in our experimental conditions by formaldehyde 364 
cross-linking. Alternatively, some interactions may be indirect through association of these 365 
proteins as partners of multiprotein complexes. 366 
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3.2. Identification of proteins that co-purify with GAPDH-V5 in the absence of cross-367 
linking  368 
Immunoprecipitation experiments with anti-V5 agarose beads were also carried out 369 
to identify proteins that interact with GAPDH without previous cross-linking. Precleared 370 
cell extracts were processed as described in section 2.5. Purified proteins were concentrated 371 
by TCA precipitation, resuspended in rehydration buffer and processed for 2D gel 372 
electrophoresis. In addition to the dominant spots corresponding to recombinant GAPDH-373 
V5 and native GAPDH forms, staining with Sypro® Ruby also revealed other proteins that 374 
co-purified with GAPDH-V5 under these conditions (Fig. 2B). An immunoprecipitation 375 
experiment starting with precleared cell extracts of TOP10 cells was performed as control. 376 
In the absence of a V5-tagged protein, no apparent spots were visible (not shown), thus 377 
ruling out co-purification of these proteins through interactions with the affinity matrix.  378 
Ten spots were excised from the 2D gel (Fig. 2B) and analysed by LC-MS/MS, in 379 
this case using a high sensitivity OrbitrapVelos mass spectrometer that enables 380 
identification of proteins even at very low amounts. Results are summarized in Table 2. 381 
Among these proteins, the ATP synthase β subunit (AtpD) and the porin OmpC, both 382 
displaying high scores in this analysis, were also identified as proteins interacting with 383 
GAPDH after formaldehyde cross-linking (Table 1). Regarding the ATP synthase α subunit 384 
(AtpA) and LpdA (both in spot 1), although these proteins were not listed in Table 1, the 385 
MS analysis performed in the cross-linking experiment revealed in both cases two peptides 386 
matching these sequences. Another protein found here to co-purify with GAPDH was GatY 387 
(30.8 kDa), the catalytic subunit of D-tagatose-1,6-bisphosphate aldolase (Brinkkötter et 388 
al., 2002). Large-scale proteomic studies performed by Burtland et al. (2005) identified the 389 
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regulatory subunit GatZ as an interacting partner of GAPDH. Neither GatY nor GatZ were 390 
identified as interacting with GAPDH in the cross-linking experiment. However, it should 391 
be noted that in this experiment, only proteins specifically present in the FA-treated sample 392 
were excised and analysed by MS. In this sense, GatY should correspond to one of the non-393 
excised protein bands with a molecular mass around 30 kDa, also visible in the control 394 
sample (Fig. 1A lane –FA versus +FA).  395 
The protein displaying the highest score in this analysis was AtpD, with 40 peptides 396 
identified that covered 85.87% of the sequence (Table 2). This ATP synthase subunit 397 
interacts with the α subunit (AtpA) to form the catalytic domain for ATP synthesis. AtpA 398 
also co-purified with GAPDH-V5, although the MS analysis yielded a lower score. In this 399 
case, 29 peptides were identified that covered 61.79 % of the sequence (Table 2).  400 
To validate interaction of GAPDH with both ATP synthase subunits, pull-down 401 
experiments with His6-tagged AtpD and AtpA proteins were performed. Recombinant His6-402 
AtpD and His6-AtpA were expressed and purified from the ASKA clones JW3710 and 403 
JW3712, respectively, as described in section 2.7. Immunoblotting of the column fractions 404 
with anti-GAPDH antibodies indicated that a fraction of GAPDH was bound and co-eluted 405 
with either His6-AtpD or His6-AtpA (Fig. 3). In a control experiment, the cell extract 406 
obtained from the host strain AG1 was directly applied to the Ni2+-NTA column and 407 
processed in parallel as a control to confirm that the Ni2+-NTA resin did not bind GAPDH 408 
to any extent (Fig. 3, right panel). It is noteworthy that even at lower bait protein 409 
concentration the GAPDH fraction recovered in these experiments was higher in the case of 410 
His6-AtpD. This suggests that co-purification and binding of GAPDH to AtpA may be 411 
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indirect through its interaction with the AtpD subunit. Alternatively, association of the 412 
AtpD and AtpA may be required to provide the interaction domain with GAPDH.  413 
It should be noted that in addition to AtpA, spot 1 contained other ATP-binding 414 
proteins such as AraG and RbsA. Abundance of these proteins in the spot should be very 415 
low given the low score and number of sequenced peptides (Table 2). Their identification 416 
may be attributed to the high sensitivity achieved with the analysis through use of the 417 
OrbitrapVelos mass spectrometer. All the proteins identified in spot 1 displayed similar 418 
molecular mass and pI, which is compatible with their inclusion in a single spot (Table 2). 419 
The fact that out of these five proteins, three contained ATP-binding domains suggests that 420 
GAPDH may display affinity for such domains. These kinds of interaction may point to a 421 
regulatory role of GAPDH in energy-dependent processes. One such process is cell 422 
motility. In this context, GAPDH has been suggested to play an important role in the 423 
motility of the halotolerant alga Dunaliella salina. In this alga, GAPDH was found in the 424 
flagellar proteome; in addition, silencing of GAPDH expression by RNAi led to reduced 425 
motility (Jia et al., 2009).  426 
A relationship between GAPDH and cellular processes involved in energy production 427 
and conversion has been observed in Streptococcus pyogenes (Jin et al., 2011). Besides its 428 
cytoplasmic location, surface export of GAPDH is essential for Streptococcus virulence. 429 
Mutants unable to export this protein, and thus expressing higher intracellular GAPDH 430 
levels, displayed an 8-fold increase in the intracellular ATP concentration with respect to 431 
the wild-type strain. Moreover, this study revealed that intracellular levels of GAPDH in 432 
some way control the expression of certain genes (Jin et al., 2011). For instance, microarray 433 
analysis of this mutant revealed up-regulation of genes encoding proton-translocating 434 
ATPases. In this context, the interaction of GAPDH with ATP synthase subunits identified 435 
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here suggests that there are additional mechanisms in the regulatory role of GAPDH in 436 
ATP-dependent processes. 437 
 438 
3.3. Analysis of GAPDH interaction with Gph 439 
 Among the proteins identified as potential GAPDH interacting partners, we found 440 
the interaction with Gph to be of special interest due to its physiological role in processes 441 
linked to DNA repair. Our group showed for the first time in bacteria that this 442 
housekeeping enzyme is involved in the dissimilation of the intracellular 2-443 
phosphoglycolate formed in the DNA repair of 3’-phosphoglycolate ends (Pellicer et al., 444 
2003). These kinds of DNA strand break are caused by bleomycin (Povirk, 1996). In 445 
mammals, involvement of GAPDH in DNA repair processes has been well-documented 446 
(Sirover, 2005; Azam et al., 2008); however no reports on a similar function were available 447 
for prokaryotic GAPDH. 448 
 First, we aimed to determine whether GAPDH copurified with recombinant Gph. To 449 
this end, cell extracts of strain BL21 bearing plasmid pGEX-Gph, and therefore expressing 450 
GST-Gph (Pellicer et al., 2003), were applied to a glutathione-sepharose 4B resin. Cell 451 
extracts expressing the tag protein GST were processed in parallel as control. After 452 
extensive washing, elution of GST or GST-Gph was performed with glutathione elution 453 
buffer. Western blot analysis of the eluted fractions indicated that GAPDH co-purified with 454 
GST-Gph but not with GST (Fig. 4A). In a parallel experiment, elution of Gph from the 455 
affinity resin was achieved by incubation with factor Xa. Western blot analysis confirmed 456 
co-elution of GAPDH (Fig. 4B). In the eluted fractions, in addition to Gph (27 kDa), two 457 
other proteins were visible. The 34 kDa protein is one of the factor Xa subunits. The 35 458 
kDa protein was excised from the gel and identified as GAPDH by MS. Moreover, pull-459 
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down experiments using His6-Gph expressed in strain AG1 from the ASKA clone JW3348 460 
as bait confirmed co-purification of GAPDH with Gph (not shown).  461 
 Overall these results confirmed interaction of GAPDH with Gph. However, when 462 
purified GAPDH was applied to an immobilized GST-Gph column, GAPDH was scarcely 463 
retained (not shown). Most of the GAPDH protein appeared in the flow-through fraction, 464 
suggesting that interaction between these proteins may either depend on other cellular 465 
factors (proteins or ligands) or on post-translational modifications of these proteins. 466 
The presence of multiple covalently modified forms of GAPDH (Aguilera et al., 2009; 467 
Egea et al., 2007) prompted us to analyse whether the Gph binding activity is specifically 468 
linked to one of these forms. This was determined by Far-Western experiments in which 469 
purified GAPDH was subjected to 2D gel electrophoresis. Once electroblotted, the 470 
membrane was reacted with purified Gph followed by incubation with specific anti-Gph 471 
antibodies. Of the multiple GAPDH spots, only one was visualized (Fig. 3C), indicating 472 
that Gph mainly interacts with a specific form of GAPDH. These results provide evidence 473 
of a direct interaction between both proteins, and indicate that it depends on a given post-474 
translational modification of GAPDH.  475 
Since human GAPDH has been shown to be involved in repairing the DNA damage 476 
generated by bleomycin or alkylating agents (Azam et al., 2008), we examined whether 477 
Gph-GAPDH interacting complexes increased in cells challenged with bleomycin. To this 478 
end, induced exponential cultures of the gph mutant strain JA210 harbouring plasmid 479 
pGEX-Gph were treated with 8 µg/ml bleomycin in the presence of 50 µM FeSO4, 480 
conditions that increase the number of DNA strand breaks to be repaired. At different 481 
times, aliquots of the culture were collected and processed to obtain the cell extracts. After 482 
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30 min exposure to bleomycin, the percentage of viable cells was found to be around 30%. 483 
Cell extracts were incubated with glutathione-sepharose 4B resin in PBS buffer. After 484 
extensive washing, GST-Gph was eluted with SDS-PAGE loading buffer. To evaluate 485 
GAPDH association, fractions were analysed by Western blotting with antibodies against 486 
GAPDH. For normalization, the same fractions were analysed in parallel with anti-GST 487 
antibodies (Fig. 5). In these experiments, the total amount of protein applied to the 488 
electrophoresis gel was lower than that used in the pull-down experiments presented in Fig. 489 
3 in order to avoid saturation of the luminescent signal in the immunoblotting analysis. As 490 
shown in Fig. 5, the number of GAPDH molecules in complex with Gph increased in 491 
bleomycin-treated cells in a time-dependent manner. Overall, these results suggest that 492 
interaction between both GAPDH and Gph is triggered under activated DNA repair 493 
conditions. These proteins are probably partners of protein complexes involved in such 494 
processes.  495 
Proteomic studies aimed at identifying protein interactions have great potential for 496 
suggesting new functions for a given protein. In fact, the presence of a protein in a 497 
multiprotein complex may be indicative that this protein has a second function (Jeffery, 498 
2009). The study presented here may provide valuable clues to identify moonlighting 499 
functions for E.coli GAPDH. In this sense, the interaction with Gph points to a GAPDH 500 
role in cellular processes linked to DNA repair. In addition, interaction between these 501 
proteins may also suggest alternative GAPDH functions in quorum sensing signalling, 502 
since in enteric bacteria 2-phosphoglycolate is also generated as a degradation product of 503 
4,5-dihydroxy-2,3-pentanedione (DPD), the precursor of the autoinducer-2 (Taga, 2007; 504 
Xavier et al., 2007). In conclusion, this study may contribute to the identification of further 505 
moonlighting functions of E. coli GAPDH at the intracellular level. 506 
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Legends to figures 627 
 628 
Fig. 1.  In vivo crosslinking of GAPDH-V5. TOP10 cells expressing GAPDH-V5 were 629 
incubated with 1% formaldehyde for 20 min (FA +) or left untreated (FA -). TOP10 cells 630 
without the recombinant plasmid pBAD-GapA were processed in parallel as control. (A) 631 
Cell extracts were analyzed by Western blotting with anti-V5 or anti-GAPDH specific 632 
antibodies. (B) Cell extracts obtained from TOP10 cells harbouring plasmid pBAD-GapA 633 
after formaldehyde cross-linking were incubated at the indicated conditions to reverse 634 
cross-links. Reversion was analyzed by Western blotting with anti-V5 antibodies. 635 
 636 
Fig. 2. Immunoaffinity purification of GAPDH-V5 interacting proteins. (A) Purification of 637 
GAPDH-V5 interacting proteins after formaldehyde cross-linking.  TOP10 cells expressing 638 
GAPDH-V5 were incubated with 1% formaldehyde for 20 min (+ FA) or left untreated (- 639 
FA). GAPDH-V5 complexes were purified from the corresponding cell extracts under 640 
astringent conditions using anti-V5 agarose beads. The purified complexes were incubated 641 
at 95ºC for 30 min to reverse cross-links and then separated by SDS-PAGE. Proteins were 642 
visualized by Sypro® Ruby staining. Twelve protein bands visible in the + FA lane 643 
(labelled by white numbers) were excised from the gel and analyzed by MS. M, molecular 644 
mass marker. (B) Two-dimensional analysis of proteins immunopreciptated with GAPDH-645 
V5 in the absence of formaldehyde cross-linking. Proteins were visualized by Sypro® 646 
Ruby staining. Ten spots (labelled by white numbers) were excised from the gel and 647 
analyzed by MS. 648 
 649 
 650 
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Fig. 3. Pull-down experiments showing binding of GAPDH to the ATP synthase α (AtpA) 651 
and β (AtpD) subunits. Cell extracts obtained from induced cells of strain AG1 bearing 652 
ASKA clone JW3710 (expressing His6-AtpD) or ASKA clone JW3712 (expressing His6-653 
AtpA) were applied to a Ni2+-NTA column. After extensive washing, elution of 654 
recombinant proteins was achieved with 300 mM imidazole (elution buffer). As a control, 655 
AG1 cell extract was applied to the Ni2+-NTA column and processed in parallel (right 656 
panel). Column fractions (FT: flow-through; W: wash; E: elution) were analyzed either by 657 
Coomassie blue staining (upper panel) or by Western blot with anti-GAPDH antibodies.  658 
 659 
Fig. 4. Binding of GAPDH to Gph. (A) Pull-down experiments showing binding of 660 
GAPDH to Gph. Cell extracts (0.5 ml; 10 mg / ml) obtained from induced cells of strain 661 
BLB21(DE3) bearing plasmid  pGEX (expressing GST) or plasmid pGEX-Gph (expressing 662 
GST-Gph) were passed over a glutathione-sepharose 4B column. After extensive washing, 663 
elution of GST or GST-Gph was achieved with glutathione elution buffer. Column 664 
fractions (FT: flow-through; W: wash; E: elution) were analyzed either by Coomassie blue 665 
staining (upper panel) or by Western blot with anti-GAPDH antibodies. (B) Co-purification 666 
of GAPDH with Gph. Gph was purified by affinity chromatography from induced cell 667 
extracts of strain BLB21(DE3) bearing plasmid pGEX-Gph (expressing GST-Gph). In this 668 
case, elution of Gph was achieved by factor Xa digestion. The eluted fractions were 669 
analyzed either by Coomassie blue staining (upper panel) or by Western blot with anti-670 
GAPDH antibodies. The 35 kDa protein band was excised from the stained gel and 671 
identified as GAPDH by MS. (C) Far-Western analysis of binding of soluble Gph to 672 
PVDF-immobilized GAPDH. Samples containing 5.0 µg of purified GAPDH were 673 
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subjected to 2D gel electrophoresis, and the gel was either silver-stained (first panel) or 674 
electroblotted. The PVDF membrane was reacted with purified Gph (5 µg/ml), 675 
subsequently incubated with antibodies against anti-Gph and processed to visualize the 676 
reactive bands (second panel).  The third panel shows the result of this analysis when the 677 
incubation step with Gph was omitted.  678 
 679 
Fig. 5. Pull-down experiments to analyze interaction of GAPDH with Gph in cells 680 
challenged with bleomycin. Induced cells of strain JA210 bearing plasmid pGEX-Gph 681 
(expressing GST-Gph) were challenged with 8 µg/ml bleomycin-50 µM de FeSO4. At the 682 
indicated times, cell extracts were obtained. Samples were incubated with glutathione-683 
sepharose 4B resin. After extensive washing, elution of GST-Gph was achieved with 684 
loading buffer 1x. Fractions were analyzed by Coomassie blue staining and by Western blot 685 
with anti-GAPDH or anti-GST antibodies.686 
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Table 1.  687 
Proteins that copurified with GAPDH-V5 after in vivo formaldehyde cross-linking  688 
Band Protein Accession kDa MASCOT score 
Peptides 
sequenced Function 
Subcellular 
localization 
1 D-ribose binding protein (RbsB) P02925 28.5 236  5 D-ribose transport Periplasm 
1 Phosphoglycolate phosphatase  P32662 27.4  99  3 Metabolic enzyme Cytoplasm 
2 GAPDH P0A9B2 36.1 447 11 Metabolic enzyme Cytoplasm 
2 OmpC P06996 40.4  91 3 Porin Outer membrane 
3 GAPDH-V5 -- -- 347 12 Recombinant protein -- 
4 EF-Tu  P0CE47 43.3 503 14 Protein synthesis Cytoplasm 
5 Enolase P0A6P9 45.6 238  5 Metabolic enzyme Cytoplasm 
6 Tryptophanase  P0A853 53.1 183  5 Metabolic enzyme Cytoplasm 
6 ATP synthase β subunit P0ABB4 50.3   98  3 ATP synthesis Inner membrane 
7 Aldehyde dehydrogrenase (AldA) P25553 52.4 284  6 Metabolic enzyme Cytoplasm 
7 Trigger factor P0A850 49.0 115  4 Chaperone Cytoplasm 
7 Pyruvate kinase P0AD61 51.6   97  3 Metabolic enzyme Cytoplasm 
8 Non identified -- -- -- -- -- -- 
9 DnaK P0A6Y8 69.1 510 10 Chaperone Cytoplasm 
10 Transketolase P27302 72.4 105  5 Metabolic enzyme Cytoplasm 
11 Aconitase P25516 94.0 135  3 Metabolic enzyme Cytoplasm 
12 Non identified -- -- -- -- -- -- 
 689 
 690 
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Table 2.  691 
Proteins that copurified with GAPDH-V5 in the absence of formaldehyde cross-linking  692 
 693 
Spot Protein Accesion kDa pI Score Peptides sequenced Function 
 
Subcellular 
localization 
 
1 ATP synthase α subunit  P0ABB0 55.2 6.13 608.59  29 ATP synthesis Membrane bound 
1 Anthranilate synthase, component II P00904 56.8 6.52  74.04 10 Trp biosynthesis Cytoplasm 
1 ATP-binding protein AraG P0AAF3 55.0 6.38 59.09 10 L-Arabinose transport   Cytoplasm 
1 ATP-binding protein RbsA P04983 55.0 6.14 50.91 11 Function Cytoplasm 
1 Dihydrolipoyl dehydrogenase (lpdA) P0A9P0 50.7 6.15 49.10 11 Pyruvate DH  component Cytoplasm 
2 Non-identified -- -- -- -- -- -- -- 
3 ATP synthase β subunit P0ABB4 50.3 5.01 1150 40 ATP synthesis Membrane bound 
4 OmpF P02931 39.3 4.96 156.9 19 Porin Outer membrane 
5 OmpC P06996 40.3 4.82 445.05  31 Porin Outer membrane 
5 GAPDH P0A9B2 35.5 7.11 153.96 19 Metabolic enzyme Cytoplasm 
6 GAPDH P0A9B2 35.5 7.11 629.11 29 Metabolic enzyme Cytoplasm 
7 / 9 /10 GAPDH proteolysis fragments P0A9B2 -- --  --  -- -- -- 
8 D-tagatose-1,6-bisphosphoaldolase, GatY P0C8J6 30.8 6.34 259.55 21 Metabolic enzyme Cytoplasm 
 694 
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